The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Out Regulatory News (TMO)

Share Price Information for Time Out (TMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 50.00
Ask: 55.00
Change: 0.00 (0.00%)
Spread: 5.00 (10.00%)
Open: 52.50
High: 52.50
Low: 52.50
Prev. Close: 52.50
TMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting

11 Jun 2020 12:05

RNS Number : 6998P
Time Out Group plc
11 June 2020
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE.

 

11 June 2020

 

Time Out Group plc

("Time Out" or the "Company")

 

Results of General Meeting

 

On 22 May 2020, Time Out announced a proposed Placing and Open Offer of New Ordinary Shares to raise, in aggregate, up to £49 million (before expenses) by way of a Placing to raise gross proceeds of £45 million and an Open Offer to raise gross proceeds of up to approximately £4 million, in each case at an issue price of 35 pence per New Ordinary Share. Subsequently, on 9 June 2020, the Company announced that 6,135,967 New Ordinary Shares were taken up under the Open Offer, including Open Offer Shares applied for pursuant to the Excess Application Facility, raising gross proceeds of approximately £2.1 million.

 

The Company is pleased to announce that at its General Meeting held earlier today, the Resolutions set out in the Notice of General Meeting incorporated into the circular published by the Company dated 23 May 2020 were duly approved.

 

Further to this, the Company can now confirm that it will issue, pursuant to the Placing and Open Offer, 134,707,395 New Ordinary Shares at 35 pence per share, raising approximately £47.1 million. The issue of New Ordinary Shares will be split as follows:

 

· 128,571,428 New Ordinary Shares under the Placing, raising gross proceeds of approximately £45 million; and

· 6,135,967 New Ordinary Shares taken up under the Open Offer, including New Ordinary Shares applied for pursuant to the Excess Application Facility, raising gross proceeds of approximately £2.1 million.

 

Application has been made for the 134,707,395 New Ordinary Shares to be admitted to trading on AIM and it is expected Admission will become effective and trading will commence in the New Ordinary Shares at 8.00 a.m. on 12 June 2020. Following Admission, the Company's issued share capital will comprise 283,201,804 Ordinary Shares. From Admission, the figure of 283,201,804 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Company can also confirm that the Incus Amendment and Restatement Agreement, pursuant to which the terms of the Incus Facility Agreement will be amended and restated (as described in the circular published by the Company dated 23 May 2020), will become effective immediately following Admission.

 

Julio Bruno, Chief Executive Officer, said:

 

"We are incredibly pleased that our Shareholders supported our successful fundraising, approving the Placing and Open Offer at today's General Meeting. Despite the current uncertainties, Time Out, as a consumer focused brand, adapted swiftly and efficiently to the needs of our audience to help them explore and experience the 'best of the city' from staying IN vs going OUT. We temporarily rebranded to 'Time In' to reflect this pivot in our mission. Preparations are now underway to reopen our Markets in line with government regulations and health and safety guidelines, such as social distancing. Our primary focus is the health and well-being of our guests, our employees, our concessionaires and their teams - we are dedicated to creating an environment that is as safe as possible but also sociable and enjoyable."

 

"With a successful equity fundraising and debt restructuring in place, we are well positioned to emerge as a stronger company following the immediate impact of COVID-19. I would like to take this opportunity to again thank our existing and new shareholders, alongside the wider team who continued to support the Time Out brand during the COVID-19 pandemic."

 

 

Defined terms used in this announcement will have the meanings (unless the context otherwise requires) set out in the circular published by the Company dated 23 May 2020, which is available on the Company's website (www.timeout.com).

 

 

For further information, please contact:

 

 

 

Time Out Group plc

Tel: +44 (0)207 813 3000

Julio Bruno, CEO

 

Adam Silver, CFO

 

Steven Tredget, Investor Relations Director

 

 

 

Liberum (Nominated Adviser and Broker)

Tel: +44 (0)203 100 2222

Clayton Bush / Andrew Godber / Edward Thomas

 

 

 

FTI Consulting LLP

Tel: +44 (0)203 727 1017

Edward Bridges / Stephanie Ellis

 

 

 

IMPORTANT NOTICES

 

This announcement is released by Time Out Group plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the Placing and Open Offer described above, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Adam Silver, Chief Financial Officer.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMFLFILRIILLII
Date   Source Headline
24th Apr 20242:58 pmRNSBlock Admissions Six Monthly Return
17th Apr 20247:00 amRNSNew Time Out Market – Budapest (Mgmt Agreement)
8th Apr 202410:32 amRNSHolding(s) in Company
4th Apr 20242:35 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSHolding(s) in Company
5th Mar 20247:00 amRNSHalf-year Report
26th Feb 20244:09 pmRNSBlock Admissions Application
2nd Feb 20243:19 pmRNSTotal Voting Rights
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSPDMR Notification
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20242:58 pmRNSTotal Voting Rights
13th Dec 20237:00 amRNSResult of Annual General Meeting
5th Dec 20237:38 amRNSTotal Voting Rights
21st Nov 20235:56 pmRNSBlock Admissions Six Monthly Return
17th Nov 20237:00 amRNSTime Out Market Cape Town Opens
15th Nov 20233:22 pmRNSNotice of AGM and Posting of Annual Report
14th Nov 20237:00 amRNSBoard Appointment
8th Nov 20237:00 amRNSFull Year Results
25th Oct 20237:00 amRNSNotice of Results
6th Sep 20238:31 amRNSTotal Voting Rights
5th Sep 20237:00 amRNSNew Time Out Market - Bahrain (Mgmt Agreement)
1st Aug 20237:00 amRNSTotal Voting Rights
30th Jun 202312:17 pmRNSBlock Admission Application
7th Jun 20239:55 amRNSTotal Voting Rights
18th May 20233:46 pmRNSBlock Admissions Six Monthly Return
18th Apr 202310:00 amRNSHolding(s) in Company
5th Apr 202312:45 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSHalf-year Report
3rd Mar 20234:57 pmRNSHolding(s) in Company
1st Mar 20233:02 pmRNSTotal Voting Rights
27th Feb 20233:17 pmRNSHolding(s) in Company
2nd Feb 20231:24 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSNew Time Out Market - Barcelona
6th Jan 20237:00 amRNSTotal Voting Rights
30th Dec 202212:03 pmRNSResult of Annual General Meeting
7th Dec 20222:50 pmRNSAnnual Report and Accounts and Notice of AGM
6th Dec 20227:00 amRNSFull Year Results
30th Nov 20227:00 amRNSNew Time Out Market - Riyadh (Mgmt Agreement)
24th Nov 20227:00 amRNSNew Loan Note Facility
8th Nov 20227:00 amRNSNew Time Out Market - Vancouver (Mgmt Agreement)
21st Oct 20227:00 amRNSBlock Admissions Six Monthly Return
7th Oct 20227:00 amRNSNew Time Out Market - Cape Town (Mgmt Agreement)
24th Aug 20227:00 amRNSLoan Facility
1st Jun 20227:00 amRNSTotal Voting Rights
19th May 20227:00 amRNSNew Time Out Market - Osaka (Mgmt Agreement)
16th May 20223:41 pmRNSHolding(s) in Company
29th Apr 202211:51 amRNSTotal Voting Rights
21st Apr 20225:09 pmRNSBlock Admissions Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.